Jadenu

Active Ingredient(s): Deferasirox
FDA Approved: * March 30, 2015
Pharm Company: * NOVARTIS PHARMS CORP
Category: Iron Chelator

Deferasirox, sold under the brand name Exjade & Asunra (in injectable form) & Oleptiss (Tablet formulation) both by Novartis among others, is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta-thalassemia and other chronic anemias.[2][3] It is the first oral medication approved in the United States for this purpose.[4] It was appro... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Jadenu 180 mg Oral Granule
NDC: 0078-0713
Labeler:
Novartis Pharmaceuticals Corporation
Jadenu 360 mg Oral Granule
NDC: 0078-0720
Labeler:
Novartis Pharmaceuticals Corporation
Jadenu 90 mg Oral Granule
NDC: 0078-0727
Labeler:
Novartis Pharmaceuticals Corporation

Related Brands

Drugs with the same active ingredients